My Companies
Notification
Account
Log Out
Back

Orchid Pharma Inks Exblifep Licensing Deal With Russian Pharmasyntez Worth $178M


7 July 2026
Orchid Pharma Ltd.

Orchid Pharma signed a licensing and supply agreement with Pharmasyntez JSC to commercialize Exblifep in Russia, with a potential opportunity of approximately USD 178 million over the first 10 years.


Recent Events

Real time WhatsApp alerts using AI.

Get features of

  • Instant Notifications
  • Competitive Advantage
  • Critical Alerts
Signup or Sign in

Company Information